Grant: Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
University of Ottawa
$66,000.00
Molecular characterization of the HIV Tat protein and its interactions with cellular proteins involved in the down regulation CD127 from the surface of CD8 T-cells
EF 2008-09
Résumé
HIV attacks cells of the immune system, killing or inactivating them and thus opening the door to opportunistic infections. How HIV affects so many cells is not understood. CD8 T cells are needed to fight viral infections including HIV. While HIV does not infect CD8 T cells it does inactive them. Our lab has shown HIV accomplishes this by sending out a messenger protein that prevents CD8 T cells from responding to infections.
CD8 T cells have a protein on their surface known as the IL-7 receptor (IL-7R). This receptor acts as the cells ears listening for danger. When an infection occurs, the body sends out many signals alerting the immune system. CD8 T cells hear the alarm in part through the IL-7R. Our lab has shown that HIV Tat protein enters CD8 T cells and removes the IL-7 receptor from the surface of the cell. This in effect deafens the cell preventing it from hearing the alarm and leaves the cell inactive.
This project is designed to understand exactly how the HIV Tat protein disables the IL-7R alarm system at the molecular level. Through genetic engineering, we will produce various mutated forms of the Tat protein, purify them, and test them for their ability to remove the IL-7R from the cell surface. From there, we will determine which regions of the Tat protein interact with the IL-7R and how Tat exploits the cellular machinery to achieve its goal.
If we know which parts of the Tat protein affect the IL-7 receptor and which cellular proteins it interacts with to remove the receptor from the cell surface, we may be able to design new therapies to disrupt this process. By maintaining the IL-7 receptor on the cell surface, CD8 T cells may be able to hear the body's alarm system and respond to infections appropriately.
Programme
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
178082
Name
Sugden Scott M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Molecular characterization of the HIV Tat protein and its interactions with cellular proteins involved in the down regulation CD127 from the surface of CD8 T-cells
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$66,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Keyworddelim
Cd127; Cell Culture; Flow Cytometry; Hiv Tat Protein; Hiv/Aids; Human Immunology; Interleukin-7; Lentiviral Gene Transduction; Primary Cd8 T Cells; Recombinant Protein Purification
Abstract
HIV attacks cells of the immune system, killing or inactivating them and thus opening the door to opportunistic infections. How HIV affects so many cells is not understood. CD8 T cells are needed to fight viral infections including HIV. While HIV does not infect CD8 T cells it does inactive them. Our lab has shown HIV accomplishes this by sending out a messenger protein that prevents CD8 T cells from responding to infections.
CD8 T cells have a protein on their surface known as the IL-7 receptor (IL-7R). This receptor acts as the cells ears listening for danger. When an infection occurs, the body sends out many signals alerting the immune system. CD8 T cells hear the alarm in part through the IL-7R. Our lab has shown that HIV Tat protein enters CD8 T cells and removes the IL-7 receptor from the surface of the cell. This in effect deafens the cell preventing it from hearing the alarm and leaves the cell inactive.
This project is designed to understand exactly how the HIV Tat protein disables the IL-7R alarm system at the molecular level. Through genetic engineering, we will produce various mutated forms of the Tat protein, purify them, and test them for their ability to remove the IL-7R from the cell surface. From there, we will determine which regions of the Tat protein interact with the IL-7R and how Tat exploits the cellular machinery to achieve its goal.
If we know which parts of the Tat protein affect the IL-7 receptor and which cellular proteins it interacts with to remove the receptor from the cell surface, we may be able to design new therapies to disrupt this process. By maintaining the IL-7 receptor on the cell surface, CD8 T cells may be able to hear the body's alarm system and respond to infections appropriately.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sugden, Scott M
Approvedterm
3 ans 0 mois
Cihrcontribution2
Science Policy 4~ $66,000~ $0~